Stocks
Alexandria Real Estate Equities, Inc.ARE
NYSEReal EstateREIT—Office$48.41-3.66%
Specializing in life science and technology campuses, this REIT owns and operates collaborative properties for pharmaceutical, biotech, and agtech tenants. Its focus on high-barrier-to-entry markets like Boston and San Francisco makes it a key player in lab space real estate. Investors monitor ARE for exposure to the growing life sciences sector and its premium urban locations.
Market Cap: $8.4B52W Range: $44.10 – $101.22
Congressional Interest in Alexandria Real Estate Equities, Inc. (ARE)
12 members of Congress have disclosed 26 trades in Alexandria Real Estate Equities, Inc. (ARE), a Real Estate company. The buy/sell breakdown shows 18 purchases versus 8 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
26
Unique Politicians
12
Buys
18
Sells
8
Who in Congress Is Trading ARE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-18 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2022-11-03 | Rohit Khanna | sell | $1K – $15K |